IMMUTEP LIMITED - Charts / Financials

4.08%

23.5¢

Market Cap $344.9M

Healthcare Biotechnology

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Day
Open	24.0¢		Day High	24.3¢		Day Low	23.5¢
Daily Volume	1709994

Bids		Sellers
Number	Price	Volume		Number	Price	Volume
14	23.5¢	1472949		3	24.0¢	142000

Directors & Senior Management

Mr. Marc Voigt	Chief Executive Officer, Executive Director
Ms. Deanne Miller	Chief Operating Officer, General Counsel, Joint Company Secretary
Dr. Frederic Triebel	Chief Scientific Officer, Executive Director
Dr. Stephan Winckels	Chief Medical Officer
Ms. Indira Naidu	Joint Company Secretary
Dr. Russell John Howard	Independent Non-Executive Chairman of the Board
Mr. Peter A. Meyers	Independent Non-Executive Deputy Chairman of the Board
Ms. Lis Boyce	Non-Executive Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 23.5¢		Change -0.010(4.08%)		Mkt cap ! $344.9M

Open	High	Low	Value	Volume
24.0¢	24.3¢	23.5¢	$408.8K	1.709M

Buyers (Bids)

No.	Vol.	Price($)
14	1472949	23.5¢

Sellers (Offers)

Price($)	Vol.	No.
24.0¢	142000	3

View Market Depth

No.	Vol.	Price($)
14	1472949	0.235
14	297206	0.230
19	485644	0.225
15	548932	0.220
6	81358	0.215

Price($)	Vol.	No.
0.240	142000	3
0.245	216840	4
0.250	183468	6
0.255	140000	4
0.260	282631	9

Last trade - 16.10pm 05/09/2025 (20 minute delay)

IMM (ASX) Chart

IMMUTEP LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories